Everolimus (certican) 12-month safety and efficacy versus mycophenolate mofetil in de Novo renal transplant recipients

2004-11-27

Transplantation , Volume 78 - Issue 10 p. 1532- 1540

Additional Metadata
Keywords	Cytomegalovirus, Everolimus, Kidney transplant, Mycophenolate mofetil, Rejection
Persistent URL	dx.doi.org/10.1097/01.TP.0000141094.34903.54, hdl.handle.net/1765/65839
Journal	Transplantation
Organisation	Department of Internal Medicine
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Vitko, S, Margreiter, R, Weimar, W, Dantal, J, Viljoen, H.G, Li, Y, … Cretin, N. (2004). Everolimus (certican) 12-month safety and efficacy versus mycophenolate mofetil in de Novo renal transplant recipients. Transplantation, 78(10), 1532–1540. doi:10.1097/01.TP.0000141094.34903.54

Publication